Cell Growth and Cytoskeletal Pathways: Experimental work suggests BPC-157 interacts with intracellular pathways involved in cell survival and migration: It influences growth factor signaling such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and elements of focal adhesion networks like FAK-paxillin complexes (2)
We advise against use in patients with active cancer, cardiovascular disease, autoimmune disorders, liver or kidney disease, clotting issues, pregnancy or breastfeeding, or those under age 20
BPC-157 appears to promote healing by modulating the nitric oxide (NO) signaling pathway, increasing the expression of growth factors such as VEGF and EGF, and regulating the activity of inflammatory mediators
This could be due to medical conditions like pernicious anemia or digestive disorders such as Crohns disease or celiac disease
Lipotropic amino acids are also eliminated naturally
See Tesamorelin Dosing, Reconstitution, and Cycle Structure in the Perfect B Peptide Protocol Tool